Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block

Debra L. Davey, Susan L. Bratton, David J. Bradley, Anji T. Yetman

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

An association between congenital complete atrioventricular block (cCAVB) and aortic dilation during childhood has recently been reported. We sought to further explore this relation with particular emphasis on the natural history of aortic abnormalities over time. The relation of maternal anti-Ro/La antibody status to the aortic size of children affected with cCAVB was also assessed. The patients were evaluated longitudinally with serial echocardiography. During a 15-year period, 62 patients at our institution were diagnosed with cCAVB, of whom 40% were exposed to maternal autoimmune antibodies and 35% were not. The antibody status in the remaining patients was unknown. The patients underwent 9.3 ± 6.5 echocardiograms during the follow-up period. Dilation of the ascending aorta, defined as a z score >2.0, was present on the initial echocardiogram in all patients exposed to maternal antibodies and persisted during long-term follow-up in 96% of these patients. In contrast, 5% and 10% of patients without exposure to maternal autoimmune antibodies had aortic dilation on the initial and follow-up studies, respectively (p <0.001 and p <0.001, respectively). In conclusion, patients with autoimmune-mediated cCAVB merit periodic echocardiographic monitoring into adulthood to assess persistent or progressive aortic dilation and its attendant complications.

Original languageEnglish (US)
Pages (from-to)561-564
Number of pages4
JournalAmerican Journal of Cardiology
Volume108
Issue number4
DOIs
StatePublished - Aug 15 2011

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block'. Together they form a unique fingerprint.

  • Cite this